ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$3.18
-0.01 (-0.31%)
Analyst Consensus
Sell
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+494.7% upside
Low Target
$12.50
Average Target
$18.91
High Target
$21.23
Current Price
$3.18
Current
$3.18
$3.18
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Scenario Analysis
Bear Case
$12.50
293.1%
Low target
Base Case
$18.91
+494.7%
Avg target
Bull Case
$21.23
+567.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.18
-23.9% from high
52-Week Low
$1.80
+76.7% from low
Target vs 52W High
$18.91
+352.4% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |